Home › Post-COVID Conditions (Long COVID) › Illinois › Chicago
Post-COVID Conditions (Long COVID) clinical trials in Chicago, IL
11 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
RecruitingPhase 3
- Rush University Medical Center ( Site 3748), Chicago
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- Northwestern Memorial Hospital, Chicago
- Northwestern University Feinberg School of Medicine, Chicago
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
RecruitingPhase 3
- Illinois Research Network (ILLInet), University of Illinois Chicago, Chicago
Dime La VerDAD: Verify, Debunk, and Disseminate
RecruitingHealthy volunteers welcome
- University of Chicago, Chicago
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
RecruitingPhase 3
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Cognitive-Sensorimotor Function in Long-COVID
RecruitingObservational studyHealthy volunteers welcome
- Jesse Brown VA Medical Center, Chicago, IL, Chicago
Dysbiosis & Long COVID
RecruitingObservational studyHealthy volunteers welcome
- The University of Chicago, Chicago
A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection
RecruitingPhase 4Healthy volunteers welcome
- University of Chicago, Chicago
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
RecruitingPhase 3
- University of Chicago Medical Center, Chicago
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
RecruitingPhase 3
- University of Illinois Health, Chicago
Convalescent Plasma as a Possible Treatment for COVID-19
RecruitingPhase 2
- University of Illinois at Chicago, Chicago
About Post-COVID Conditions (Long COVID)
Anyone who had COVID-19 can have ongoing symptoms. Learn about post-COVID conditions (long COVID), including symptoms, diagnosis, treatments, and prevention.
More about Post-COVID Conditions (Long COVID) on MedlinePlus
Post-COVID Conditions (Long COVID) trials in other cities
- New York City, NY15 studies
- Houston, TX13 studies
- Boston, MA13 studies
- Baltimore, MD12 studies
- Washington, DC10 studies
- San Francisco, CA8 studies
- Durham, NC8 studies
- Atlanta, GA8 studies
- San Diego, CA7 studies
- Los Angeles, CA6 studies
- Pittsburgh, PA6 studies
- Hialeah, FL6 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer59 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Lung Cancer41 studies
- Obesity41 studies
- Ovarian Cancer36 studies
- Colorectal Cancer34 studies
- Stroke34 studies
- Heart Failure31 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.